Clinical Connect Hie

“Question 12c: All Board Members must disclose annually, at a minimum, any Interests that they currently hold, or expect in the near future to hold, through the Conflict of Interest Disclosure Statement. If, during the course of any given year, a Board Member becomes aware of a new actual or potential or otherwise undisclosed Interest, the Board Member must update the Conflict of Interest Disclosure Statement. All disclosed Interests shall be tracked and monitored by the Clinical Connect HIE President or his/her delegate(s). Prior to any Board of Director decision, the Clinical Connect HIE President or his/her delegate(s) shall review the disclosed Interests to determine whether any held by a Board Member have the potential or potential appearance of compromising the integrity or independence of that Board Member's judgment when fulfilling his/her governance responsibilities on behalf of Clinical Connect HIE. In such case, the President or his/her delegate(s) shall refer the matter to the Clinical Connect HIE Chairman of the Board or Vice-Chairman of the Board (in the case of a conflict involving the Chairman). Question 19: Upon request, management determines public disclosure applicability. PENNSYLVANIA AND ELSEWHERE; (II) TO IMPROVE THE QUALITY AND EFFICIENCY OF HEALTH CARE BY IMPROVING THE TIMELINESS OF DECISIONS ABOUT PATIENT CARE AND INTEGRATING INFORMATION FROM VARIOUS SOURCES; (III) TO IMPROVE THE ABILITY TO COORDINATE AND MAKE STRATEGIC DECISIONS BY FACILITATING THE INTEGRATION OF HEALTH CARE RELATED INFORMATION, AND (IV) TO REDUCE THE COST OF CARE BY AVOIDING THE UNNECESSARY DUPLICATION OF TESTS AND PROCEDURES. THE FEDERAL GOVERNMENT AND THE COMMONWEALTH OF PENNSYLVANIA HAVE OBJECTIVELY MANIFESTED THAT THE DEVELOPMENT, IMPLEMENTATION, AND OPERATION OF HEALTH INFORMATION EXCHANGES IS A GOVERNMENT BURDEN. MOST NOTABLY, THE LEGISLATIVE HISTORY OF AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009 SPECIFICALLY RECOGNIZES THAT NONPROFIT ORGANIZATIONS FORMED TO FACILITATE THE EXCHANGE OF HEALTH-RELATED INFORMATION MAY QUALIFY AS ORGANIZATIONS DESCRIBED IN SECTION 501(C)(3) AS ORGANIZATIONS THAT RELIEVE THE BURDENS OF GOVERNMENT. IN FREQUENTLY ASKED QUESTIONS, THE IRS ACKNOWLEDGED THAT SUCH LEGISLATIVE HISTORY SERVES AS A BASIS FOR HEALTH INFORMATION EXCHANGE ORGANIZATIONS TO OBTAIN TAX-EXEMPT STATUS UNDER SECTION 501(C)(3). BECAUSE CLINICALCONNECT'S HEALTH INFORMATION EXCHANGE ACTIVITY IS A BURDEN OF GOVERNMENT, AND BECAUSE CLINICALCONNECT'S HEALTH INFORMATION EXCHANGE ACTIVITY DOES IN FACT RELIEVE SUCH BURDEN, CLINICALCONNECT IS AN ORGANIZATION THAT RELIEVES THE BURDENS OF GOVERNMENT UNDER SECTION 501(C)(3). IN ADDITION, BY DEVELOPING, IMPLEMENTING, OPERATING A HEALTH INFORMATION EXCHANGE, CLINICALCONNECT WILL PROMOTE HEALTH IN THE COMMUNITY, AND ADVANCE EDUCATION, ALL WITHIN THE MEANING OF SECTION 501(C)(3).”

“Question 12c: all board members must disclose annually, at a minimum, any interests that they currently hold, or expect in the near future to hold, through the conflict of interest disclosure statement. If, during the course of any given year, a board member becomes aware of a new actual or potential or otherwise undisclosed interest, the board member must update the conflict of interest disclosure statement. All disclosed interests shall be tracked and monitored by the clinicalconnect hie president or his/her delegate(s). Prior to any board of director decision, the clinicalconnect hie president or his/her delegate(s) shall view the disclosed interests to determine whether any held by a board member have the potential or potential appearance of compromising the integrity or independence of that board member's judgment when fulfilling his/her governance responsibilities on behalf of clinicalconnect hie. In such case, the president or his/her delegate(s) shall refer the matter to the clinicalconnect hie chairman of the board or vice-chairman of the board (in the case of a conflict involving the chairman). Question 19: upon request, management determines public disclosure applicability.”

“Member capital contributions $1,987,430”